4/17/2025This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)

4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...

4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...

3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...

3/25/2025Novo Nordisk and the United Labs Announce License Deal for UBT251

3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...

3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...

3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief

2/19/2025CSPC Pharma Partners with Radiance for Global Development of Anticance...

2/18/2025How China and Indian Biotech are Teaming Up to Conquer the Global Mark...

2/14/2025China Approves Novo Nordisk's Semaglutide Injection for New Indication

2/13/2025Global PE Firms Compete to Acquire Majority Stake in Gland Pharma from...

2/11/2025Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...

1/28/2025China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...

1/24/2025Hengrui's Insulin Degludec BLA Accepted by China's NMPA

1/17/2025Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...

1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...

1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...

12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray

12/23/2024CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...

12/18/2024Gan & Lee Cleared for the U.S. IND for Bi-weekly GLP-1RA GZR18 Injecti...

12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia

12/10/2024Eli Lilly Plans to Launch Weight Loss Drug in China Soon

12/9/2024Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...

12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...

11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China

Page:1/18 Total number of articles:524: [First][<<] [1] [2] [3] [4] [5] [>>] [End]